These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32902984)

  • 21. G protein-coupled receptor 84 controls osteoclastogenesis through inhibition of NF-κB and MAPK signaling pathways.
    Park JW; Yoon HJ; Kang WY; Cho S; Seong SJ; Lee HW; Yoon YR; Kim HJ
    J Cell Physiol; 2018 Feb; 233(2):1481-1489. PubMed ID: 28574596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PET Imaging of Innate Immune Activation Using
    Kalita M; Park JH; Kuo RC; Hayee S; Marsango S; Straniero V; Alam IS; Rivera-Rodriguez A; Pandrala M; Carlson ML; Reyes ST; Jackson IM; Suigo L; Luo A; Nagy SC; Valoti E; Milligan G; Habte F; Shen B; James ML
    JACS Au; 2023 Dec; 3(12):3297-3310. PubMed ID: 38155640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective antagonists of mouse trace amine-associated receptor 1 (mTAAR1): discovery of EPPTB (RO5212773).
    Stalder H; Hoener MC; Norcross RD
    Bioorg Med Chem Lett; 2011 Feb; 21(4):1227-31. PubMed ID: 21237643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On-target and off-target effects of novel orthosteric and allosteric activators of GPR84.
    Mancini SJ; Mahmud ZA; Jenkins L; Bolognini D; Newman R; Barnes M; Edye ME; McMahon SB; Tobin AB; Milligan G
    Sci Rep; 2019 Feb; 9(1):1861. PubMed ID: 30755705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The GPR84 Antagonist GLPG1205 Reduces Features of Disease in Experimental Severe Asthma.
    Donovan C; Thorpe AE; Gomez HM; Carroll OR; Feng M; Bai X; Chen H; Horvat JC; Oliver BGG; Kim RY
    Am J Respir Cell Mol Biol; 2024 May; 70(5):424-427. PubMed ID: 38690993
    [No Abstract]   [Full Text] [Related]  

  • 26. Discovery and characterization of 2-(cyclopropanesulfonamido)-N-(2-ethoxyphenyl)benzamide, ML382: a potent and selective positive allosteric modulator of MrgX1.
    Wen W; Wang Y; Li Z; Tseng PY; McManus OB; Wu M; Li M; Lindsley CW; Dong X; Hopkins CR
    ChemMedChem; 2015 Jan; 10(1):57-61. PubMed ID: 25209672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of cellular dielectric spectroscopy, a whole-cell, label-free technology for drug discovery on Gi-coupled GPCRs.
    Peters MF; Knappenberger KS; Wilkins D; Sygowski LA; Lazor LA; Liu J; Scott CW
    J Biomol Screen; 2007 Apr; 12(3):312-9. PubMed ID: 17307886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery and Characterization of Novel Antagonists of the Proinflammatory Orphan Receptor GPR84.
    Jenkins L; Marsango S; Mancini S; Mahmud ZA; Morrison A; McElroy SP; Bennett KA; Barnes M; Tobin AB; Tikhonova IG; Milligan G
    ACS Pharmacol Transl Sci; 2021 Oct; 4(5):1598-1613. PubMed ID: 34661077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of GPR84 deletion on obesity and diabetes development in mice fed long chain or medium chain fatty acid rich diets.
    Du Toit E; Browne L; Irving-Rodgers H; Massa HM; Fozzard N; Jennings MP; Peak IR
    Eur J Nutr; 2018 Aug; 57(5):1737-1746. PubMed ID: 28429080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-Activity Relationship Studies and Optimization of 4-Hydroxypyridones as GPR84 Agonists.
    Ieremias L; Kaspersen MH; Manandhar A; Schultz-Knudsen K; Vrettou CI; Pokhrel R; Heidtmann CV; Jenkins L; Kanellou C; Marsango S; Li Y; Bräuner-Osborne H; Rexen Ulven E; Milligan G; Ulven T
    J Med Chem; 2024 Mar; 67(5):3542-3570. PubMed ID: 38381650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: Implications for optimizing preclinical neuroscience drug discovery.
    Sengmany K; Singh J; Stewart GD; Conn PJ; Christopoulos A; Gregory KJ
    Neuropharmacology; 2017 Mar; 115():60-72. PubMed ID: 27392634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-Throughput Screening for Allosteric Modulators of GPCRs.
    Bertekap RL; Burford NT; Li Z; Alt A
    Methods Mol Biol; 2015; 1335():223-40. PubMed ID: 26260604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65.
    Huang XP; Karpiak J; Kroeze WK; Zhu H; Chen X; Moy SS; Saddoris KA; Nikolova VD; Farrell MS; Wang S; Mangano TJ; Deshpande DA; Jiang A; Penn RB; Jin J; Koller BH; Kenakin T; Shoichet BK; Roth BL
    Nature; 2015 Nov; 527(7579):477-83. PubMed ID: 26550826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonist.
    Brotherton-Pleiss CE; Dillon MP; Ford AP; Gever JR; Carter DS; Gleason SK; Lin CJ; Moore AG; Thompson AW; Villa M; Zhai Y
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1031-6. PubMed ID: 20045645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medium-chain fatty acid-sensing receptor, GPR84, is a proinflammatory receptor.
    Suzuki M; Takaishi S; Nagasaki M; Onozawa Y; Iino I; Maeda H; Komai T; Oda T
    J Biol Chem; 2013 Apr; 288(15):10684-91. PubMed ID: 23449982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory changes in adipose tissue enhance expression of GPR84, a medium-chain fatty acid receptor: TNFα enhances GPR84 expression in adipocytes.
    Nagasaki H; Kondo T; Fuchigami M; Hashimoto H; Sugimura Y; Ozaki N; Arima H; Ota A; Oiso Y; Hamada Y
    FEBS Lett; 2012 Feb; 586(4):368-72. PubMed ID: 22245676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural insights into ligand recognition and activation of the medium-chain fatty acid-sensing receptor GPR84.
    Liu H; Zhang Q; He X; Jiang M; Wang S; Yan X; Cheng X; Liu Y; Nan FJ; Xu HE; Xie X; Yin W
    Nat Commun; 2023 Jun; 14(1):3271. PubMed ID: 37277332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probe dependence in the allosteric modulation of a G protein-coupled receptor: implications for detection and validation of allosteric ligand effects.
    Valant C; Felder CC; Sexton PM; Christopoulos A
    Mol Pharmacol; 2012 Jan; 81(1):41-52. PubMed ID: 21989256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three classes of ligands each bind to distinct sites on the orphan G protein-coupled receptor GPR84.
    Mahmud ZA; Jenkins L; Ulven T; Labéguère F; Gosmini R; De Vos S; Hudson BD; Tikhonova IG; Milligan G
    Sci Rep; 2017 Dec; 7(1):17953. PubMed ID: 29263400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Acting at Site Distinct from 2-Methyl-6-(phenylethynyl)-pyridine Binding.
    Butkiewicz M; Rodriguez AL; Rainey SE; Wieting J; Luscombe VB; Stauffer SR; Lindsley CW; Conn PJ; Meiler J
    ACS Chem Neurosci; 2019 Aug; 10(8):3427-3436. PubMed ID: 31132237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.